In clinical practice, the Ki-67 index can guide treatment decisions. For example, in breast cancer, a high Ki-67 index may indicate the need for more aggressive treatment such as chemotherapy, while a low Ki-67 index might suggest that less aggressive treatments, like hormone therapy, could be sufficient. It is also used to stratify patients into different risk categories, helping to tailor treatment plans more precisely.
